Please upgrade your browser.
The center is launching its Moon Shots ProgramÂÂ as a way to rally up researchers, and put an end to cancer.
48% greater risk of kidney cancer seen among those with gum disease.
The Supreme Court is hearing a case which could well determine whether patients grappling with deadly diseases can have access to affordable generic medicines.
Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
This phase II trial is studying how well sunitinib works as first-line therapy in treating patients with locally advanced or metastatic papillary renal cell (kidney) cancer.
"We invite kidney cancer advocates from around the world to join us for this inaugural event..."
âWeâre pleased to announce the formation of an international collaboration of cancer patient organizations aimed at speeding innovative treatments from the bench to the bedside,â says Bill Bro, CEO of the Kidney Cancer Association (KCA), the worldâs largest charity dedicated to the eradication of death and suffering from renal cancers.
Inconsistent epidemiological findings, debate over interpretation, and extrapolation of findings from animal studies to humans have produced uncertainty surrounding the carcinogenicity of trichloroethylene (TCE) exposure in occupational settings.
To be held in Arezzo, Italy, on October 18-19, 2012.
Personalized medicine is the future. Itâs where the science is going. Itâs where the technology is going. Itâs where doctors and patients will want to go. Yet, unfortunately for many of us, this is not where the Obama administration wants to go.
The September, 2012, edition of the Kidney Cancer Association's monthly video magazine includes a story about how depression affects cancer survival, along with a presentation by StÃ©phane Oudard, MD, PhD, "Vaccines in the Era of TKI: Much Ado About Nothing?"
|Powered by NeonCRM|